Could Nutraceutical Approaches Possibly Attenuate the Cytokine Storm in COVID-19 Patients?

Vignesh, Ramachandran; Velu, Vijayakumar; Sureban, Sripathi M

Vignesh, Ramachandran; Velu, Vijayakumar; Sureban, Sripathi M.

Afiliação

Vignesh R; Preclinical Department, Royal College of Medicine Perak (UniKL RCMP), Universiti Kuala Lumpur, Ipoh, Malaysia.
Velu V; Infectious Diseases Laboratory, YR Gaitonde Centre for AIDS Research and Education (YRG CARE), Chennai, India.
Sureban SM; Department of Pathology & Laboratory Medicine, Emory University School of Medicine, Division of Microbiology & Immunology, Yerkes National Primate Center, Atlanta, GA, United States.

Front Cell Infect Microbiol ; 11: 667733, 2021.

Article em En | MEDLINE | ID: mdl-33968808

Assuntos

COVID-19; Microbioma Gastrointestinal; Síndrome da Liberação de Citocina; Suplementos Nutricionais; Humanos; SARS-CoV-2

Palavras-chave

COVID-19; Pectin; SARS-CoV-2; gut microbiota; nutraceuticals; probiotics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Microbioma Gastrointestinal / COVID-19 Limite: Humans Idioma: En Revista: Front Cell Infect Microbiol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Malásia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google